Abstract
Purpose
Adrenocortical lesions are characterized through imaging, hormonal and histopathological analysis. Our aim was to compare the radiological features of adrenocortical lesions with their cortisol-secreting status and histopathological Weiss score.
Methods
Seventy five patients operated between 2004 and 2016 in the University Hospital of Nancy for either adrenocortical carcinomas (ACC) or adrenocortical adenomas (ACA) were enrolled in this study. We collected cortisol parameters, Computed Tomography (CT) scans (unenhanced density, wash-out (WO) analysis) and 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) datas. The histopathological Weiss score ultimately differentiates ACA (score ≤ 2) from ACC (score ≥ 3). One-way ANOVA, Fisher’s exact and unpaired t tests were used for statistical analysis with significancy reached at p < 0.05.
Results
There were 23 ACC and 52 ACA with 40 patients (53%) who had an autonomous secretion of cortisol. On CT scan, ACC were larger compared to ACA (108 vs. 37 mm, p < 0.0001). A roughly similar proportion of cortisol-secreting (22/25) and non-secreting (15/19) ACA were atypical (i.e., unenhanced density value ≥ 10 Hounsfield Units [HU]), however 85% of cortisol-secreting vs. 40% of non-secreting ACA were classified as benigns by the relative WO analysis (p = 0.08). Likewise, there was a trend for a higher 18F-FDG uptake in cortisol-secreting ACA compared to non-secreting ACA (p = 0.053).
Conclusions
The relative adrenal WO analysis consolidates the benign nature of an ACA, especially in case of cortisol oversecretion, a condition known to compromise the diagnostic accuracy of the 10 HU unenhanced CT attenuation threshold.
Similar content being viewed by others
References
J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith, The incidental adrenal mass on CT: Prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. Am. J. Roentgenol. 190, 1163–1168 (2008)
W.F. Young, Clinical practice. The incidentally discovered adrenal mass. N. Engl. J. Med. 356, 601–610 (2007).
M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164, 851–870 (2011)
A. Frilling, K. Tecklenborg, F. Weber, H. Kühl, S. Müller, G. Stamatis, C. Broelsch, Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 136, 1289–1296 (2004)
M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev, A. Tabarin, M. Terzolo, S. Tsagarakis, O.M. Dekkers, Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175, G1–G34 (2016)
J.H. Song, D.J. Grand, M.D. Beland, K.J. Chang, J.T. Machan, W.W. Mayo-Smith, Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone? Ajr. Am. J. Roentgenol. 201, 1248–1253 (2013)
A. Sahdev, J. Willatt, I.R. Francis, R.H. Reznek, The indeterminate adrenal lesion. Cancer Imaging 10, 102–113 (2010)
C. Chambre, E. McMurray, C. Baudry, M. Lataud, L. Guignat, S. Gaujoux, N. Lahlou, J. Guibourdenche, F. Tissier, M. Sibony, B. Dousset, X. Bertagna, J. Bertherat, P. Legmann, L. Groussin, The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas. Eur. J. Endocrinol. 173, 325–332 (2015)
M.A. Blake, M.K. Kalra, A.T. Sweeney, B.C. Lucey, M.M. Maher, D.V. Sahani, E.F. Halpern, P.R. Mueller, P.F. Hahn, G.W. Boland, Distinguishing Benign from Malignant Adrenal Masses: Multi–Detector Row CT Protocol with 10-Minute Delay 1. Radiology 238, 578–585 (2006)
C.S. Peña, G.W. Boland, P.F. Hahn, M.J. Lee, P.R. Mueller, Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217, 798–802 (2000)
L. Groussin, G. Bonardel, S. Silvéra, F. Tissier, J. Coste, G. Abiven, R. Libé, M. Bienvenu, J.-L. Alberini, S. Salenave, P. Bouchard, J. Bertherat, B. Dousset, P. Legmann, B. Richard, H. Foehrenbach, X. Bertagna, F. Tenenbaum, 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J. Clin. Endocrinol. Metab. 94, 1713–1722 (2009)
C. Guerin, F. Pattou, L. Brunaud, J.-C. Lifante, E. Mirallié, M. Haissaguerre, D. Huglo, P. Olivier, C. Houzard, C. Ansquer, E. Hindié, A. Loundou, C. Archange, A. Tabarin, F. Sebag, K. Baumstarck, D. Taïeb, Performance of 18F-FDG PET/CT in the characterization of adrenal masses in noncancer patients: a prospective study. J. Clin. Endocrinol. Metab. 102, 2465–2472 (2017)
G.W.L. Boland, B.A. Dwamena, M. Jagtiani Sangwaiya, A.G. Goehler, M.A. Blake, P.F. Hahn, J.A. Scott, M.K. Kalra, Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 259, 117–126 (2011)
L.M. Weiss, Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol. 8, 163–169 (1984)
M. Korobkin, T.J. Giordano, F.J. Brodeur, I.R. Francis, E.S. Siegelman, L.E. Quint, N.R. Dunnick, J.P. Heiken, H.H. Wang, Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 200, 743–747 (1996)
E.M. Caoili, M. Korobkin, I.R. Francis, R.H. Cohan, N.R. Dunnick, Delayed enhanced CT of lipid-poor adrenal adenomas. Am. J. Roentgenol. 175, 1411–1415 (2000)
B.K. Park, B. Kim, K. Ko, S.Y. Jeong, G.Y. Kwon, Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: Pathological correlation. Eur. Radiol. 16, 642–647 (2006)
A. Kutikov, K. Mallin, D. Canter, Y.-N. Wong, R.G. Uzzo, Effects of increased cross sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the national cancer data base. J. Urol. 186, 805–810 (2011)
T.M.A. Kerkhofs, R.H.A. Verhoeven, J.M. Van der Zwan, J. Dieleman, M.N. Kerstens, T.P. Links, L.V. Van, de Poll-Franse, H.R. Haak, Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur. J. Cancer 49, 2579–2586 (2013)
A.O. Ciftci, M.E. Şenocak, F.C. Tanyel, N. Büyükpamukçu, Adrenocortical tumors in children. J. Pediatr. Surg. 36, 549–554 (2001)
T. Kerkhofs, M. Ettaieb, R. Verhoeven, G. Kaspers, W. Tissing, J. Loeffen, M. Van den Heuvel-Eibrink, R. De Krijger, H. Haak, Adrenocortical carcinoma in children: First population‑based clinicopathological study with long-term follow-up. Oncol. Rep. 32, 2836–2844 (2014)
D. Patel, S.K. Gara, R.J. Ellis, M. Boufraqech, N. Nilubol, C. Millo, C.A. Stratakis, E. Kebebew, FDG PET/CT scan and Ffnctional adrenal tumors: a pilot study for lateralization. World J. Surg. 40, 683–689 (2016)
N. Jin, W. Qian, X. Yin, L. Zhang, K. Iqbal, I. Grundke-Iqbal, C.-X. Gong, F. Liu, CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease. Nucleic Acids Res. 41, 3240–3256 (2013)
F. Beuschlein, M. Fassnacht, G. Assié, D. Calebiro, C.A. Stratakis, A. Osswald, C.L. Ronchi, T. Wieland, S. Sbiera, F.R. Faucz, K. Schaak, A. Schmittfull, T. Schwarzmayr, O. Barreau, D. Vezzosi, M. Rizk-Rabin, U. Zabel, E. Szarek, P. Salpea, A. Forlino, A. Vetro, O. Zuffardi, C. Kisker, S. Diener, T. Meitinger, M.J. Lohse, M. Reincke, J. Bertherat, T.M. Strom, B. Allolio, Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N. Engl. J. Med. 370, 1019–1028 (2014)
D. Calebiro, G. Di Dalmazi, K. Bathon, C.L. Ronchi, F. Beuschlein, cAMP signaling in cortisol-producing adrenal adenoma. Eur. J. Endocrinol. 173, M99–M106 (2015)
G. Di Dalmazi, R. Pasquali, F. Beuschlein, M. Reincke, Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur. J. Endocrinol. 173, M61–M71 (2015)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Humbert, AL., Lecoanet, G., Moog, S. et al. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas. Endocrine 59, 529–537 (2018). https://doi.org/10.1007/s12020-018-1522-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-018-1522-7